Myriad Genetics said its FirstGene Multiple Prenatal Screen achieved at least 98.2% sensitivity and 99.0% specificity in analytical validation, a strong data po

Myriad Genetics said its FirstGene Multiple Prenatal Screen achieved at least 98.2% sensitivity and 99.0% specificity in analytical validation, a strong data point for non-invasive prenatal testing. It assesses multiple markers from a single blood draw.